New $7.7 Million Grant To Propel Search for Drugs for Rare Brain Disorder

Rumbaugh and a team of scientists from the institute have been awarded a five-year grant from the National Institute of Mental Health worth $7.7 million to work toward a treatment. Their goal is to create a pill that restores healthy SYNGAP1 gene production, thereby boosting neuroplasticity, or the ability of the brain to form circuits and connections.

UF Graduate Student Start-Up Focuses on Creating Chemicals From Ocean Microbes

In Jules Verne’s 20,000 Leagues Under the Sea, Captain Nemo describes the sea as “everything,” the “vast reservoir of Nature.” A pair of UF Ph.D. students are diving into these vast depths. They are harnessing the power of marine microbes and unlocking their potential for sustainable chemical applications. Jessica Tittl Nielsen (CEO) and Monica Schul (Chief Science Officer) founded a biotechnology company, Cordelia Biosciences, to create sustainable chemicals from ocean microbes.

Space-Focused Accelerator Begins Process for Applicants

The Space-Edge Accelerator, an innovation-focused collaboration between the University of Florida, Blue Origin, Space Foundation, the University of Central Florida, Arizona State University, and Vanderbilt University, is opening applications for its inaugural program.

Access Pediatric Joins ARPA-H Investor Catalyst Hub to Improve Pediatric Specialty Care

Access Pediatric, a virtual-first, pediatric telehealth platform connecting patients with specialty pediatric physicians, is one of the newest members of the ARPA-H Investor Catalyst Hub. The group includes more than 300 organizations facilitating research findings and future-forward ideas to advance commercialization, affordability, and revolutionary breakthroughs to achieve improved health outcomes for all Americans. Access Pediatric, […]